Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Centre for Probe Development and Evaluation (CPDE) is a specialized clinical research organization and research center focused on the translation of radiopharmaceuticals from the bench to the bedside. Located in Hamilton, Ontario, CPDE operates in close partnership with the Centre for Probe Development and Commercialization (CPDC) and McMaster University. The organization provides essential services for the life sciences sector, including radiochemistry development, regulatory submission support, and the management of multi-center clinical trials for molecular imaging probes. By offering expertise in the evaluation of novel diagnostic and therapeutic agents, CPDE accelerates the development of precision medicine tools for oncology, neurology, and cardiology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centre for Probe Development and Evaluation.